Centrifugal Blood Pumps Market Analysis

Product Type (Electrical, Mechanical)

Based on product type electrical segment is projected to dominate centrifugal blood pumps market share of around 77.2% by the end of 2037. Compared to roller pumps, electronic centrifugal blood pumps have the advantage of a less noticeable systemic inflammatory response and less damage to red blood cells, which promotes segment growth. For instance, in February 2023, it was published in Micromachines that a screw centrifugal blood pump was examined with a multi-objective gray wolf optimization algorithm in addition to a random forest optimization method. The hemolysis value dropped by 48% and the pressure generation increased by 24%. Thus, technical breakthroughs are serving as a catalyst for the growth in the market.

Application (Short-Term Support, Long-Term Support)

The long-term support segment in the centrifugal blood pumps market is likely to garner lucrative growth opportunities during the forecast period. The increasing need for long-term solutions to manage chronic cardiovascular conditions is further fueling the demand in the market. These systems have become indispensable instruments in the management of complex cardiovascular conditions. In addition, technological advancements in long-term support systems have improved their reliability and patient comfort. For instance, in May 2024, as per news published by the Food & Drug Administration, HeartMate 3 LVAS, by Abbott Laboratories can be used in adults and pediatric patients with severe left ventricular heart failure. This system can be used for both short- and long-term support.

Our in-depth analysis of the global market includes the following segments: